Beam Therapeutics(BEAM) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2026 Registrant's Telephone Number, Including Area Code: 857 327-8775 (Former Name or Former Address, if Changed Since Last Report) Beam Therapeutics Inc. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) Delaware 001-39208 81-5238 ...